Status:
UNKNOWN
Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia
Lead Sponsor:
All India Institute of Medical Sciences
Conditions:
Pulmonary Hypertension Secondary to Lung Disease and/or Hypoxia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is an open label, randomized, interventional study indented to find the efficacy of different treatment regimens in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia.Th...
Detailed Description
This is an open label, randomized, interventional study indented to find the efficacy of different treatment regimens in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia. I...
Eligibility Criteria
Inclusion
- Pulmonary artery hypertension diagnosed by doppler echocardiography as mean pulmonary artery pressure 25 mmHg (done in department of cardiology, AIIMS)
- Age more than 18 years
- Pulmonary artery hypertension due to hypoxia, either chronic obstructive airway disease or diffuse pulmonary lung disease
- Willing to consent to participate in the trial
- WHO functional class I,II, III
Exclusion
- WHO functional class IV
- Patient participating in any other trial
- Concomitant coronary artery disease
- Nitrate intake
- Liver dysfunction
- Pregnancy and lactation -
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01449253
Start Date
August 1 2011
End Date
July 1 2013
Last Update
January 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute Of Medical Sciences
New Delhi, National Capital Territory of Delhi, India, 110029